We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“In addition to established indications such as ACS and heart failure, the guidelines highlight that patients after surgical or transcatheter aortic valve replacement, with congenital heart disease, with atrial fibrillation or with cancer undergoing potentially cardiotoxic cancer therapies may benefit. Importantly, frailty, older age and comorbidities are not reasons to withhold cardiac rehabilitation.”
“In the guidelines, we speak of cardiac rehabilitation as a multi-component intervention that also addresses mental health and provides education. Improving health literacy and greater self-management can lead to sustainable lifestyle changes and increased adherence with medical therapies.”
“Cardiac rehabilitation is one of the most effective treatments in cardiovascular care, which provides positive effects beyond medication or surgery alone. Despite the growing number of people living with cardiovascular diseases, cardiac rehabilitation is still underused across Europe and elsewhere. The new guidelines provide the opportunity to highlight the benefits of cardiac rehabilitation and also include practical information on how it should be implemented, which is lacking in some guidelines focused on specific conditions.”
No takes yet. Share an insight, caveat, or question.
Bäck et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: